Literature DB >> 8193354

Molecular cloning of two isoforms of the murine homolog of the myeloid CD33 antigen.

E Z Tchilian1, P C Beverley, B D Young, S M Watt.   

Abstract

CD33 monoclonal antibodies recognize a 67-kD glycoprotein of unknown function that is expressed by early myeloid progenitors and their leukemic counterparts. We report here the cloning of the murine homolog of the human CD33 antigen. Two cDNA clones, differing by an 83-nucleotide insertion in the cytoplasmic region, were isolated. The insertion generated a shift in the reading frame within the cytoplasmic tail, resulting in two mouse CD33 isoforms, m33-A and m33-B, with distinct cytoplasmic domains and with predicted protein core molecular weights of 37 kD and 45 kD, respectively. The cDNAs and deduced amino acid sequences show extensive similarity with the human CD33 sequence with the highest homology occurring in the first and second lg-like domains (61% amino acid identity). The most significant divergence between the human and murine proteins occurs in their cytoplasmic portions. The murine CD33 mRNAs were detected in bone marrow, spleen, thymus, brain, liver, the multipotential progenitor cell line, A4, the myelomonocytic cell line, WEHI3B, the myeloid cell line, M1, and the macrophage cell line, P388, by Northern blot analysis. The expression pattern of the murine CD33 homolog suggests that the function of CD33 antigen in hematopoiesis may be conserved between humans and mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8193354

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

Review 1.  Siglecs in the immune system.

Authors:  P R Crocker; A Varki
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

2.  Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice.

Authors:  Ricky Cheung; Fran Shen; Joseph H Phillips; Mandy J McGeachy; Daniel J Cua; Paul G Heyworth; Robert H Pierce
Journal:  J Clin Invest       Date:  2011-10-17       Impact factor: 14.808

Review 3.  The Sialoadhesins--a family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily.

Authors:  S Kelm; R Schauer; P R Crocker
Journal:  Glycoconj J       Date:  1996-12       Impact factor: 2.916

Review 4.  Basic and clinical immunology of Siglecs.

Authors:  Stephan von Gunten; Bruce S Bochner
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

5.  Sialylation of neurites inhibits complement-mediated macrophage removal in a human macrophage-neuron Co-Culture System.

Authors:  Bettina Linnartz-Gerlach; Christine Schuy; Anahita Shahraz; Andrea J Tenner; Harald Neumann
Journal:  Glia       Date:  2015-08-10       Impact factor: 7.452

Review 6.  Efficacy and resistance of gemtuzumab ozogamicin for acute myeloid leukemia.

Authors:  Akihiro Takeshita
Journal:  Int J Hematol       Date:  2013-05-26       Impact factor: 2.490

7.  CD33/Siglec-3 binding specificity, expression pattern, and consequences of gene deletion in mice.

Authors:  Els C M Brinkman-Van der Linden; Takashi Angata; Shirley A Reynolds; Leland D Powell; Stephen M Hedrick; Ajit Varki
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

8.  Negative regulation of Toll-like receptor-4 signaling through the binding of glycosylphosphatidylinositol-anchored glycoprotein, CD14, with the sialic acid-binding lectin, CD33.

Authors:  Akiko Ishida; Kaoru Akita; Yugo Mori; Shuhei Tanida; Munetoyo Toda; Mizue Inoue; Hiroshi Nakada
Journal:  J Biol Chem       Date:  2014-07-24       Impact factor: 5.157

Review 9.  Sialic acids in molecular and cellular interactions.

Authors:  S Kelm; R Schauer
Journal:  Int Rev Cytol       Date:  1997

10.  Cellular transcriptional alterations of peripheral blood in Alzheimer's disease.

Authors:  Liting Song; Yucheng T Yang; Qihao Guo; Xing-Ming Zhao
Journal:  BMC Med       Date:  2022-08-29       Impact factor: 11.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.